|
|
 |
|
Viewing report
|
|
|
|
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
GBI Research, Feb 2010, Pages: 181
“Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global biotechnology industry and analyzes the competitive positioning of the top 10 companies in the industry. This pharmaceutical and healthcare report estimates the market size of the global biotechnology industry and its future prospects. It benchmarks the leading companies in the biotechnology industry on selected parameters to analyze their competitive positioning in the market. The report analyzes the future landscape of the biotechnology industry by forecasting the revenues of leading companies to 2012. For each company the report analyzes the financial strength, product portfolio, pipeline strength and therapeutic focus of its R&D activities. It critically examines the strengths and weaknesses of individual companies and the opportunities and threats facing them. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Scope
The report analyses the competitive landscape of the biotechnology industry, R&D strategies and pipeline of the top 10 players, and strengths, weaknesses, opportunities and threats facing these companies. Its scope includes
- Market size of the global biotechnology industry and coverage of the changing competitive landscape from 2008 to 2012.
- Review of key industry drivers and restraints which are likely to impact the global biotechnology industry in the future.
- Analysis of the competitive positioning of the top 10 biotechnology companies globally.
- Analysis of pipeline products in the global biotech market by therapy area like cancer, infectious diseases, respiratory disorders, autoimmune disorders, and product classes.
- Financial analysis including annual revenues of top 10 companies from 2004 to 2008, with forecasts to 2012.
- SWOT analysis, DuPont analysis and financial benchmarking of the top 10 biotech companies.
- Analysis of the therapeutic focus, marketed products and product pipeline of top 10 biotech companies.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop a clear knowledge and understanding of the competitive landscape and how this will change in the coming years.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Make more informed business decisions from the insightful and in-depth analysis of the key strategies to be followed by competitors.
- Effectively plan your investment strategies by identifying companies with maximum investment potential.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Executing Change: Survival Strategies of Big Biotech
Global Top 10 Biotechnology Companies — Industry, Financial and SWOT Analysis
Top 50 Biotechnology Companies & Their Pipelines 2010
Top 50 Biotechnology Companies & Their Pipelines 2011
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition
Partnering Agreements in Pharma and Biotech Yearbook 2010
Biotechnology - Global Outlook
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition
Pre-Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
|
|
|
|
